EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER

André Vinicius Zolesi, Danielle Vieira Sobral, Flávio Lopes Alves, Fernanda Ferreira Mendonça, Luciana Malavolta, Leonardo Lima Fuscaldi

Hematology, Transfusion and Cell Therapy · 2026-03 · 48 · 106278

DOI: 10.1016/j.htct.2026.106278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-03. Verfasst von André Vinicius Zolesi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Zolesi, A. V., Sobral, D. V., Alves, F. L., Mendonça, F. F., Malavolta, L., & Fuscaldi, L. L. (2026). STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER. Hematology, Transfusion and Cell Therapy, 48, 106278. https://doi.org/10.1016/j.htct.2026.106278

Vancouver

Zolesi AV, Sobral DV, Alves FL, Mendonça FF, Malavolta L, Fuscaldi LL. STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER. Hematology, Transfusion and Cell Therapy. 2026;48:106278. doi:10.1016/j.htct.2026.106278

BibTeX
@article{Zolesi2026,
  author = {Zolesi, André Vinicius and Sobral, Danielle Vieira and Alves, Flávio Lopes and Mendonça, Fernanda Ferreira and Malavolta, Luciana and Fuscaldi, Leonardo Lima},
  title = {STRUCTURALLY MODIFIED IKAV PEPTIDES AS BIOLOGICALLY ACTIVE LIGANDS IN TRIPLE-NEGATIVE BREAST CANCER},
  journal = {Hematology, Transfusion and Cell Therapy},
  year = {2026},
  volume = {48},
  pages = {106278},
  doi = {10.1016/j.htct.2026.106278}
}
Kostenlos starten →